Use of commercially available natural language processing software to identify bleeding from the medical record

Author:

Walker Andrew L.,Watson Cheri,Butcher Ryan,Abedin Zameer,Yandell Mark,Shah Rashmee U.

Abstract

AbstractBackgroundReal-world evidence derived from the electronic medical record (EMR) is increasingly prevalent. How best to ascertain cardiovascular outcomes from EMRs is unknown. We sought to validate a commercially available natural language processing (NLP) software to extract bleeding events.MethodsWe included patients with atrial fibrillation and cancer seen at our cancer center from 1/1/2016 to 12/31/2019. A query set based on SNOMED CT expressions was created to represent bleeding from 11 different organ systems. We ran the query against the clinical notes and randomly selected a sample of notes for physician validation. The primary outcome was the positive predictive value (PPV) of the software to identify bleeding events stratified by organ system.ResultsWe included 1370 patients with mean age 72 years old (SD 1.5) and 35% female. We processed 66,130 notes; the NLP software identified 6522 notes including 654 unique patients with possible bleeding events. Among 1269 randomly selected notes, the PPV of the software ranged from 0.921 for neurologic bleeds to 0.571 for OB/GYN bleeds. Patterns related to false positive bleeding events identified by the software included historic bleeds, hypothetical bleeds, missed negatives, and word errors.ConclusionsNLP may provide an alternative for population-level screening for bleeding outcomes in cardiovascular studies. Human validation is still needed, but an NLP-driven screening approach may improve efficiency.

Publisher

Cold Spring Harbor Laboratory

Reference8 articles.

1. Impact of Different Electronic Cohort Definitions to Identify Patients With Atrial Fibrillation From the Electronic Medical Record;J. Am. Heart Assoc,2020

2. Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study;Circ. Cardiovasc. Qual. Outcomes,2021

3. Office of the Commissioner. Real-World Evidence. U.S. Food and Drug Administration https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence (2020).

4. The Promise of Big Data and Digital Solutions in Building a Cardiovascular Learning System: Opportunities and Barriers;Methodist Debakey Cardiovasc. J,2020

5. RESEARCH PROTOCOL: Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3